LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
13.62
+0.28 (2.06%)
Nov 20, 2026, 2:24 PM EST - Market open
LifeStance Health Group Revenue
LifeStance Health Group had revenue of $455.86M in the quarter ending September 30, 2026, with 25.30% growth. This brings the company's total for the last twelve months to $1.68B, up 22.62% year-over-year. In the year 2025, LifeStance Health Group had annual revenue of $1.42B with 13.85% growth. That makes LifeStance Health Group the 5,598th largest company in the world by revenue and 1,427th in the United States.
Revenue (ttm)
$1.68B
Revenue Growth
+22.62%
P/S Ratio
3.02
Revenue / Employee
$189,201
Employees
8,863
Market Cap
5.18B
Revenue by Segment
- Commercial 1.28B 90.0%
- Government 76.14M 5.3%
- Self-Pay 56.19M 3.9%
- Nonpatient Service 10.63M 0.7%
Fiscal year ended Dec 31, 2025 See the full LifeStance Health Group breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.42B | 173.32M | 13.85% |
| Dec 31, 2024 | 1.25B | 195.31M | 18.50% |
| Dec 31, 2023 | 1.06B | 196.12M | 22.82% |
| Dec 31, 2022 | 859.54M | 192.03M | 28.77% |
| Dec 31, 2021 | 667.51M | 401.96M | 151.36% |
| Dec 31, 2020 | 265.56M | 53.04M | 24.96% |
| Dec 31, 2019 | 212.52M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Universal Health Services | 18.35B |
| DaVita | 14.17B |
| Option Care Health | 5.75B |
| PACS Group | 5.71B |
| The Ensign Group | 5.67B |
| Acadia Healthcare Company | 3.41B |
| Surgery Partners | 3.36B |
| Chemed | 2.66B |
LFST News
- 8 days ago - LifeStance price target raised to $15 from $13 at JPMorgan - TheFly
- 9 days ago - LifeStance price target raised to $18 from $15 at Barclays - TheFly
- 11 days ago - LifeStance Health Group Announces Pricing of Secondary Public Offering - GlobeNewsWire
- 11 days ago - LifeStance Health Group Announces Launch of Secondary Public Offering - GlobeNewsWire
- 14 days ago - LifeStance price target raised to $17 from $13 at Morgan Stanley - TheFly
- 14 days ago - LifeStance price target raised to $17 from $15 at KeyBanc - TheFly
- 14 days ago - LifeStance price target raised to $16 from $15 at Canaccord - TheFly
- 14 days ago - LifeStance price target raised to $18 from $15.50 at Jefferies - TheFly